Indigenous Brazilian Children Are First in World to Get Paediatric Treatment for Relapsing Malaria 23/04/2026 Kerry Cullinan Brazilian children from the Yanomami indigenous community will be the first in the world to get a single-dose paediatric treatment for relapsing malaria. The introduction of paediatric tafenoquine, developed by Medicines for Malaria Venture (MMV) and pharmaceutical company GSK, marks a “major step” towards closing the treatment gap for children at risk of relapsing Plasmodium […] Continue reading -> One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Available Cervical Cancer Vaccines Fail to Cover the HPV 35 Genotype Common in Africa 26/03/2026 Elaine Ruth Fletcher The Human papillomavirus (HPV35), globally associated with only 2% of invasive cervical cancers (ICC), has a disproportionately higher prevalence in sub‐Saharan Africa, reaching rates of 22-30% in some countries among women with ICC lesions, according to a new study. Recently, a high-level panel called for redoubled efforts in HPV vaccination, screening and treatment to meet […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access 14/04/2026 Kerry Cullinan The United States and the Global Fund will support three million people to get lenacapavir, the twice-a-year HIV injection that is almost 100% successful in preventing transmission of the virus – a million more than their previous commitment. Jeremy Lewin, US Under Secretary of State for Foreign Assistance, Humanitarian Affairs and Religious Freedom at the […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Available Cervical Cancer Vaccines Fail to Cover the HPV 35 Genotype Common in Africa 26/03/2026 Elaine Ruth Fletcher The Human papillomavirus (HPV35), globally associated with only 2% of invasive cervical cancers (ICC), has a disproportionately higher prevalence in sub‐Saharan Africa, reaching rates of 22-30% in some countries among women with ICC lesions, according to a new study. Recently, a high-level panel called for redoubled efforts in HPV vaccination, screening and treatment to meet […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Available Cervical Cancer Vaccines Fail to Cover the HPV 35 Genotype Common in Africa 26/03/2026 Elaine Ruth Fletcher The Human papillomavirus (HPV35), globally associated with only 2% of invasive cervical cancers (ICC), has a disproportionately higher prevalence in sub‐Saharan Africa, reaching rates of 22-30% in some countries among women with ICC lesions, according to a new study. Recently, a high-level panel called for redoubled efforts in HPV vaccination, screening and treatment to meet […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery 31/03/2026 Kerry Cullinan Scientists working on new malaria drugs now have access to an open-access artificial intelligence (AI)-powered platform aimed at accelerating drug discovery, thanks to a partnership between Medicines for Malaria Venture (MMV) and deepmirror. Drug Design for Global Health (dd4gh) uses “both predictive and generative AI to give researchers, especially those in the most resource-limited settings, […] Continue reading -> Available Cervical Cancer Vaccines Fail to Cover the HPV 35 Genotype Common in Africa 26/03/2026 Elaine Ruth Fletcher The Human papillomavirus (HPV35), globally associated with only 2% of invasive cervical cancers (ICC), has a disproportionately higher prevalence in sub‐Saharan Africa, reaching rates of 22-30% in some countries among women with ICC lesions, according to a new study. Recently, a high-level panel called for redoubled efforts in HPV vaccination, screening and treatment to meet […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Available Cervical Cancer Vaccines Fail to Cover the HPV 35 Genotype Common in Africa 26/03/2026 Elaine Ruth Fletcher The Human papillomavirus (HPV35), globally associated with only 2% of invasive cervical cancers (ICC), has a disproportionately higher prevalence in sub‐Saharan Africa, reaching rates of 22-30% in some countries among women with ICC lesions, according to a new study. Recently, a high-level panel called for redoubled efforts in HPV vaccination, screening and treatment to meet […] Continue reading -> Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unlocking the Power of the Private Sector for Stronger Health Systems 06/03/2026 Elaine Ruth Fletcher As USAID programmes funding vital treatments for HIV/AIDS, malaria, maternal and child health, and other critical needs were imploding across Africa last year, a for-profit social enterprise startup geared up for its first real test. Using medicines procurement as its lever, the Swiss-based startup Axmed called for a radical reboot of national systems — to […] Continue reading -> Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Investment in Malaria Venture Yields 13x Health Benefits 17/02/2026 Kerry Cullinan Every $1 invested in the Medicines for Malaria Venture (MMV) between 2000 and 2023 yielded $13 in monetised health benefits, according to a study published in The Lancet Global Health this week. MMV is a not-for-profit product development partnership (PDP) that works with public and private sector partners to discover, develop and deliver accessible and […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Brain Health Is Not an Abstract Policy Issue, It Is a Lived Reality 31/01/2026 Health Policy Watch “You start with, as in my case, with the loss of three generations of my family to various forms of Alzheimer’s or dementia.” Those were the words of George Vradenburg. For him, brain health is not an abstract policy issue. It is a lived reality that mirrors a fast-growing global crisis. This issue was the […] Continue reading -> Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems 21/01/2026 Kerry Cullinan The Gates Foundation and OpenAI announced a $50 million “pilot” on Wednesday to “advance AI capabilities for health” in Africa. Horizon 1000 promises “funding, technology, and technical support” to roll out AI solutions to 1,000 African primary healthcare clinics by 2028. “AI is going to be a scientific marvel no matter what, but for it […] Continue reading -> Posts navigation Older posts